nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—PSIP1—brainstem—narcolepsy	0.0388	0.092	CbGeAlD
L-DOPA—PSIP1—forebrain—narcolepsy	0.0374	0.0888	CbGeAlD
L-DOPA—PSIP1—medulla oblongata—narcolepsy	0.0271	0.0642	CbGeAlD
L-DOPA—PSIP1—midbrain—narcolepsy	0.0247	0.0586	CbGeAlD
L-DOPA—SLC7A8—forebrain—narcolepsy	0.0247	0.0585	CbGeAlD
L-DOPA—DDC—brainstem—narcolepsy	0.0221	0.0525	CbGeAlD
L-DOPA—DDC—forebrain—narcolepsy	0.0214	0.0506	CbGeAlD
L-DOPA—DRD5—forebrain—narcolepsy	0.0205	0.0487	CbGeAlD
L-DOPA—DRD1—brainstem—narcolepsy	0.0163	0.0386	CbGeAlD
L-DOPA—DRD1—forebrain—narcolepsy	0.0157	0.0372	CbGeAlD
L-DOPA—PSIP1—brain—narcolepsy	0.0155	0.0368	CbGeAlD
L-DOPA—DDC—midbrain—narcolepsy	0.0141	0.0334	CbGeAlD
L-DOPA—SLC7A5—medulla oblongata—narcolepsy	0.0138	0.0328	CbGeAlD
L-DOPA—DRD4—brain—narcolepsy	0.0129	0.0307	CbGeAlD
L-DOPA—SLC7A5—midbrain—narcolepsy	0.0126	0.03	CbGeAlD
L-DOPA—DRD1—midbrain—narcolepsy	0.0104	0.0246	CbGeAlD
L-DOPA—SLC7A8—brain—narcolepsy	0.0102	0.0243	CbGeAlD
L-DOPA—DRD2—brainstem—narcolepsy	0.0096	0.0228	CbGeAlD
L-DOPA—DRD2—forebrain—narcolepsy	0.00927	0.022	CbGeAlD
L-DOPA—DRD3—brain—narcolepsy	0.00909	0.0216	CbGeAlD
L-DOPA—DDC—brain—narcolepsy	0.00886	0.021	CbGeAlD
L-DOPA—DRD5—brain—narcolepsy	0.00852	0.0202	CbGeAlD
L-DOPA—SLC7A5—brain—narcolepsy	0.00794	0.0188	CbGeAlD
L-DOPA—DRD1—brain—narcolepsy	0.00651	0.0154	CbGeAlD
L-DOPA—DRD2—midbrain—narcolepsy	0.00612	0.0145	CbGeAlD
L-DOPA—CYP2D6—brainstem—narcolepsy	0.00577	0.0137	CbGeAlD
L-DOPA—CYP2D6—forebrain—narcolepsy	0.00557	0.0132	CbGeAlD
L-DOPA—DRD2—brain—narcolepsy	0.00385	0.00912	CbGeAlD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00234	0.00405	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—P2RY11—narcolepsy	0.00233	0.00403	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00232	0.00401	CbGpPWpGaD
L-DOPA—DRD4—GPCRs, Other—HTR2A—narcolepsy	0.00231	0.004	CbGpPWpGaD
L-DOPA—CYP2D6—brain—narcolepsy	0.00231	0.00548	CbGeAlD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00231	0.00399	CbGpPWpGaD
L-DOPA—DRD4—G alpha (i) signalling events—HRH3—narcolepsy	0.00217	0.00376	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HCRTR1—narcolepsy	0.00217	0.00375	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HCRTR2—narcolepsy	0.00217	0.00375	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00215	0.00372	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00215	0.00372	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HCRTR2—narcolepsy	0.00214	0.0037	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HCRTR1—narcolepsy	0.00214	0.0037	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—P2RY11—narcolepsy	0.0021	0.00362	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00209	0.00361	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00208	0.00359	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—P2RY11—narcolepsy	0.00207	0.00358	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00206	0.00356	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Other—HTR2A—narcolepsy	0.00206	0.00355	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—NPS—narcolepsy	0.00204	0.00353	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—TRH—narcolepsy	0.00203	0.00352	CbGpPWpGaD
L-DOPA—DRD4—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00202	0.00349	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—PENK—narcolepsy	0.00198	0.00343	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—HCRT—narcolepsy	0.00198	0.00342	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00197	0.00341	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00194	0.00335	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00194	0.00335	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—HRH3—narcolepsy	0.00193	0.00334	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HCRTR1—narcolepsy	0.00185	0.00319	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HCRTR2—narcolepsy	0.00185	0.00319	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—NPS—narcolepsy	0.00184	0.00318	CbGpPWpGaD
L-DOPA—DRD1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00182	0.00314	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—NPS—narcolepsy	0.00181	0.00313	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00179	0.0031	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—P2RY11—narcolepsy	0.00178	0.00308	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—HRH3—narcolepsy	0.00178	0.00308	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HCRT—narcolepsy	0.00178	0.00308	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00177	0.00307	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00177	0.00306	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—PENK—narcolepsy	0.00176	0.00305	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HCRT—narcolepsy	0.00176	0.00304	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00175	0.00303	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00173	0.00299	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CHKB—narcolepsy	0.00171	0.00296	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HCRTR1—narcolepsy	0.00168	0.0029	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HCRTR2—narcolepsy	0.00168	0.0029	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HCRTR1—narcolepsy	0.00164	0.00283	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HCRTR2—narcolepsy	0.00164	0.00283	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—P2RY11—narcolepsy	0.00162	0.0028	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—PENK—narcolepsy	0.00159	0.00275	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—P2RY11—narcolepsy	0.00158	0.00274	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00158	0.00272	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—PENK—narcolepsy	0.00157	0.00271	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00156	0.00269	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00153	0.00265	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HCRT—narcolepsy	0.00152	0.00262	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—TRH—narcolepsy	0.0015	0.00259	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—NPS—narcolepsy	0.00148	0.00255	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—TAC1—narcolepsy	0.00148	0.00255	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—HRH3—narcolepsy	0.00148	0.00255	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00143	0.00248	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00143	0.00248	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—NPS—narcolepsy	0.00139	0.0024	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HCRT—narcolepsy	0.00138	0.00238	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00137	0.00237	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00136	0.00236	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00136	0.00236	CbGpPWpGaD
L-DOPA—DRD5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00136	0.00236	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—PENK—narcolepsy	0.00135	0.00234	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—TRH—narcolepsy	0.00135	0.00234	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.00135	0.00233	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00134	0.00232	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—TRH—narcolepsy	0.00133	0.0023	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—P2RY11—narcolepsy	0.00132	0.00228	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—HRH3—narcolepsy	0.00132	0.00228	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00129	0.00223	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00129	0.00223	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00127	0.0022	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00127	0.0022	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HCRTR1—narcolepsy	0.00124	0.00214	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HCRTR2—narcolepsy	0.00124	0.00214	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—PENK—narcolepsy	0.00123	0.00212	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00123	0.00212	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00123	0.00212	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00121	0.00209	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00121	0.00209	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—PENK—narcolepsy	0.0012	0.00207	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—P2RY11—narcolepsy	0.0012	0.00207	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.00118	0.00205	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HRH3—narcolepsy	0.00118	0.00205	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00117	0.00203	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—P2RY11—narcolepsy	0.00117	0.00202	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HRH3—narcolepsy	0.00117	0.00202	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00117	0.00202	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CPT1B—narcolepsy	0.00116	0.00201	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—TRH—narcolepsy	0.00115	0.00199	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HCRT—narcolepsy	0.00112	0.00193	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00111	0.00193	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.00111	0.00193	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.00111	0.00193	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HCRTR2—narcolepsy	0.0011	0.0019	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HCRTR1—narcolepsy	0.0011	0.0019	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—TAC1—narcolepsy	0.00109	0.00189	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—NPS—narcolepsy	0.00109	0.00189	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—P2RY11—narcolepsy	0.00108	0.00186	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—P2RY11—narcolepsy	0.00106	0.00184	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—TRH—narcolepsy	0.00104	0.0018	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—TRH—narcolepsy	0.00102	0.00176	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HCRT—narcolepsy	0.00102	0.00176	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HRH3—narcolepsy	0.00101	0.00174	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HCRT—narcolepsy	0.00101	0.00174	CbGpPWpGaD
L-DOPA—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00101	0.00174	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—PENK—narcolepsy	0.000997	0.00172	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HCRT—narcolepsy	0.000994	0.00172	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HCRTR2—narcolepsy	0.00099	0.00171	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HCRTR1—narcolepsy	0.00099	0.00171	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—NPS—narcolepsy	0.000982	0.0017	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—TAC1—narcolepsy	0.000982	0.0017	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000973	0.00168	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000973	0.00168	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—TAC1—narcolepsy	0.000968	0.00167	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—NPS—narcolepsy	0.000968	0.00167	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—P2RY11—narcolepsy	0.000957	0.00165	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000926	0.0016	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000926	0.0016	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HRH3—narcolepsy	0.000915	0.00158	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HCRT—narcolepsy	0.000915	0.00158	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PENK—narcolepsy	0.000906	0.00157	CbGpPWpGaD
L-DOPA—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000905	0.00156	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HCRT—narcolepsy	0.000903	0.00156	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—PENK—narcolepsy	0.000898	0.00155	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.000894	0.00155	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.000894	0.00155	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000893	0.00154	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—HTR2A—narcolepsy	0.000889	0.00154	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—PENK—narcolepsy	0.000886	0.00153	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000861	0.00149	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—TRH—narcolepsy	0.000848	0.00147	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.000841	0.00145	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.000841	0.00145	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—NPS—narcolepsy	0.000835	0.00144	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—TAC1—narcolepsy	0.000835	0.00144	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—PENK—narcolepsy	0.000815	0.00141	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HCRT—narcolepsy	0.000813	0.00141	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.000812	0.0014	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PENK—narcolepsy	0.000804	0.00139	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000775	0.00134	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TRH—narcolepsy	0.00077	0.00133	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000765	0.00132	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—TRH—narcolepsy	0.000763	0.00132	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.000761	0.00132	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—TAC1—narcolepsy	0.000758	0.00131	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—NPS—narcolepsy	0.000758	0.00131	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—TRH—narcolepsy	0.000753	0.0013	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HRH3—narcolepsy	0.000744	0.00129	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—NPS—narcolepsy	0.000741	0.00128	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.000741	0.00128	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HCRTR2—narcolepsy	0.000731	0.00126	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HCRTR1—narcolepsy	0.000731	0.00126	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PENK—narcolepsy	0.000725	0.00125	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—P2RY11—narcolepsy	0.000706	0.00122	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TRH—narcolepsy	0.000693	0.0012	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.000691	0.00119	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TRH—narcolepsy	0.000684	0.00118	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000683	0.00118	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.000678	0.00117	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HRH3—narcolepsy	0.000675	0.00117	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HRH3—narcolepsy	0.000669	0.00116	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HRH3—narcolepsy	0.000661	0.00114	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HCRTR2—narcolepsy	0.000658	0.00114	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HCRTR1—narcolepsy	0.000658	0.00114	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—HTR2A—narcolepsy	0.000656	0.00113	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HCRTR2—narcolepsy	0.000649	0.00112	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HCRTR1—narcolepsy	0.000649	0.00112	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—P2RY11—narcolepsy	0.000636	0.0011	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—P2RY11—narcolepsy	0.000627	0.00108	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TRH—narcolepsy	0.000616	0.00107	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—NPS—narcolepsy	0.000616	0.00107	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—TAC1—narcolepsy	0.000616	0.00107	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PENK—narcolepsy	0.000616	0.00106	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HRH3—narcolepsy	0.000608	0.00105	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HCRT—narcolepsy	0.0006	0.00104	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HRH3—narcolepsy	0.0006	0.00104	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HTR2A—narcolepsy	0.00059	0.00102	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000585	0.00101	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HTR2A—narcolepsy	0.000583	0.00101	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.000576	0.000997	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—NPS—narcolepsy	0.00056	0.000968	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TAC1—narcolepsy	0.00056	0.000968	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—NPS—narcolepsy	0.000555	0.000959	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—TAC1—narcolepsy	0.000555	0.000959	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—TAC1—narcolepsy	0.000547	0.000946	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—NPS—narcolepsy	0.000547	0.000946	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HRH3—narcolepsy	0.00054	0.000935	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HCRT—narcolepsy	0.00054	0.000934	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PENK—narcolepsy	0.000535	0.000925	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HCRT—narcolepsy	0.000533	0.000922	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TRH—narcolepsy	0.000523	0.000905	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HRH3—narcolepsy	0.000505	0.000874	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TAC1—narcolepsy	0.000504	0.000871	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—NPS—narcolepsy	0.000504	0.000871	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HTR2A—narcolepsy	0.000502	0.000868	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—NPS—narcolepsy	0.000497	0.000859	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TAC1—narcolepsy	0.000497	0.000859	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HCRTR1—narcolepsy	0.000497	0.000859	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HCRTR2—narcolepsy	0.000497	0.000859	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PENK—narcolepsy	0.000482	0.000833	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—P2RY11—narcolepsy	0.00048	0.00083	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PENK—narcolepsy	0.000475	0.000822	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HRH3—narcolepsy	0.000459	0.000794	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HTR2A—narcolepsy	0.000456	0.000789	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TRH—narcolepsy	0.000455	0.000787	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NPS—narcolepsy	0.000448	0.000774	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TAC1—narcolepsy	0.000448	0.000774	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HTR2A—narcolepsy	0.000446	0.000771	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—NPS—narcolepsy	0.000419	0.000724	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—TAC1—narcolepsy	0.000419	0.000724	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TRH—narcolepsy	0.00041	0.000708	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HCRT—narcolepsy	0.000408	0.000705	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TRH—narcolepsy	0.000404	0.000699	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HRH3—narcolepsy	0.000399	0.00069	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CHKB—narcolepsy	0.000394	0.000681	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TAC1—narcolepsy	0.00038	0.000658	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—NPS—narcolepsy	0.00038	0.000658	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR2A—narcolepsy	0.000371	0.000641	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PENK—narcolepsy	0.000364	0.000629	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HRH3—narcolepsy	0.000359	0.000621	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HRH3—narcolepsy	0.000354	0.000613	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR2A—narcolepsy	0.000337	0.000582	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR2A—narcolepsy	0.000334	0.000577	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TAC1—narcolepsy	0.000331	0.000572	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NPS—narcolepsy	0.000331	0.000572	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR2A—narcolepsy	0.000329	0.000569	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TRH—narcolepsy	0.000309	0.000535	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR2A—narcolepsy	0.000303	0.000524	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR2A—narcolepsy	0.000299	0.000517	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NPS—narcolepsy	0.000298	0.000515	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TAC1—narcolepsy	0.000298	0.000515	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NPS—narcolepsy	0.000294	0.000508	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TAC1—narcolepsy	0.000294	0.000508	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HRH3—narcolepsy	0.000271	0.000469	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR2A—narcolepsy	0.000269	0.000466	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000268	0.000463	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	0.000252	0.000436	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2A—narcolepsy	0.000229	0.000396	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NPS—narcolepsy	0.000225	0.000388	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TAC1—narcolepsy	0.000225	0.000388	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2A—narcolepsy	0.000199	0.000344	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2A—narcolepsy	0.000179	0.00031	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2A—narcolepsy	0.000177	0.000305	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2A—narcolepsy	0.000135	0.000234	CbGpPWpGaD
